# Can You Advertise TRT on Meta?

Reviewed October 5, 2026 · By Michael Borgia, MedScale Health

## Short answer

As of October 2026, yes, in two layers. Ads for the clinic, the labs and the visit run without authorization, because Meta exempts ads that promote telehealth services generally. Naming testosterone or any prescription product needs active LegitScript certification and Meta's authorization, and those ads may only target people 18 and over in the United States, Canada or New Zealand. MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs TRT on Meta lab-first and keeps every ad off the viewer's body.

## What this means for you

- Clinic-layer ads run today: the labs, the visit, the provider and the price, with no prescription product named. Meta needs no authorization for ads that promote telehealth services generally.
- Ads that name testosterone or any prescription product need active LegitScript certification, Meta's authorization, a consult-a-professional disclaimer, and targeting limited to people 18 and over in the United States, Canada or New Zealand.
- "Low T?" fails Meta's personal attributes rule. "Testosterone therapy with a licensed provider" does not. The subject of every line is the program, never the viewer.
- Testosterone is a Schedule III controlled substance, so the visit model and the claims draw extra scrutiny.
- Nothing about a visitor's health goes back to Meta through the pixel. Health information is on Meta's own list of data it does not want.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs Meta campaigns for men's health brands whose product is a program with labs, a prescriber visit and a partner pharmacy. This page sets out the Meta rules that decide whether such a brand can advertise, and what it can say at each stage. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

## The prescription drug rule, in Meta's words

Meta's Drugs and Pharmaceuticals policy allows ads that promote prescription drugs only from qualified advertisers. Online pharmacies and telehealth providers must be actively certified with LegitScript, then request authorization from Meta. Once authorized, they may only target people 18 or older, only in the United States, Canada or New Zealand, and only in countries where they hold certification. Every prescription drug ad also needs a disclaimer telling people to consult a licensed health professional or obtain a valid prescription.

The same policy lists two kinds of ads that need no written authorization: ads that educate, advocate or give public service announcements about prescription drugs, and ads that promote telehealth services generally. That second exemption is where a new TRT brand starts. An ad for a men's health program with labs and a licensed provider is a telehealth service ad. An ad that names testosterone cypionate, shows a vial or prices a dose is a prescription drug ad.

## The personal attributes rule and men's health hooks

Meta's Privacy Violations and Personal Attributes policy says ads must not assert or imply personal attributes, including physical or mental health and medical conditions. Meta's own examples draw the line: "New diabetes treatment available" passes, "Do you have diabetes?" fails. Men's health hooks break this rule often, because the obvious openers are questions about the viewer's energy, mood or body.

- Fails: "Low T?", "Tired all the time?", "Not the man you used to be?"
- Passes: "Testosterone therapy, prescribed by licensed providers", "Hormone testing first, then a plan from a clinician", "Men's health care with labs included".

Meta's policy allows "you" and "your" on their own. The problem is pairing them with a health condition. Moving the subject of the sentence onto the program fixes most rejections in one pass.

## Testosterone is a controlled substance

Testosterone is listed in Schedule III of the federal controlled substances schedules (21 CFR 1308.13). Prescribing it by telemedicine without an in-person visit relies on the DEA's temporary telemedicine flexibilities, which the fourth extension (Federal Register document 2025-24123) keeps in effect through December 31, 2026. A brand's visit model, prescriber licences and ad promises all need to fit those rules and each state's rules, and that end date is worth watching.

LegitScript's write-up of its telehealth advertising webinar adds a creative point: testosterone carries heightened scrutiny, and platforms watch for messaging that frames it as a performance enhancer rather than a hormone treatment. Muscle, performance and sexual-prowess angles invite rejection. Labs, clinicians and follow-up care do not.

## Age and the health rules

Meta's Health and Wellness policy requires ads for health products and services to target people 18 and over. It also bars clickbait in a health context, such as sensational claims or promises of a specific outcome within a set timeframe without disclaimers or qualifiers. If the program also treats sexual health concerns, Meta's reproductive health rules add one more condition: the ad must focus on health and medical efficacy, not pleasure or enhancement. Shirtless or sexualised creative pulls an ad toward the enhancement reading, so MedScale leaves it out.

## The landing page and the pixel are reviewed too

A compliant ad that lands on a page listing testosterone with prices and an add-to-cart button is a prescription drug ad in practice. Until the brand is certified and authorized, the page leads with the program, the lab panel and the visit, and medication details sit inside the intake. Once authorized, the page can name products, with the prescription requirement stated plainly.

The pixel matters as much as the copy. Meta's Business Help Center lists health information, including medical conditions, treatments and prescription medications, as prohibited information that advertisers must not share through its business tools. Event names such as trt_consult_booked, or page addresses that carry a drug name, send exactly that. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform.

## Running both layers side by side

The clinic layer is not a placeholder while certification is pending. It stays the core of the account after authorization arrives. Authorization adds a second set of campaigns, in their own ad sets, that may name products. LegitScript's webinar write-up puts the rule simply: a campaign is held to the requirements of its most regulated product, so consultation ads and product ads never share an ad set.

## What MedScale does

MedScale Health runs TRT acquisition on Meta in this order: a policy read of every live ad, page and pixel event; clinic-layer campaigns built around labs, the provider and the price; server-side tracking with neutral event names; and, where the brand wants to name products, LegitScript certification help and the Meta authorization request alongside the running campaigns. Approval and results are never guaranteed. The free growth audit at medscale.health/audit reads your current account against these rules and comes back with a written plan.

## FAQ

**Can a TRT clinic run Facebook ads without LegitScript?**

Yes, for ads that promote the telehealth service generally: the labs, the visit, the provider and the price. Meta's policy exempts those from authorization. Naming testosterone or another prescription product needs LegitScript certification and Meta's authorization first.

**Why was our "Low T?" ad rejected?**

Meta's personal attributes policy bars ads that assert or imply a viewer's medical condition, and a question about low testosterone implies the viewer has it. Rewrite so the program is the subject, then submit new copy rather than the same ad with small edits.

**Which countries can authorized TRT ads target on Meta?**

Only the United States, Canada and New Zealand, and only countries where the advertiser holds certification. Every prescription drug ad must also target people 18 or older and carry a disclaimer to consult a licensed health professional or obtain a valid prescription.

**Does testosterone being a controlled substance change what we can advertise?**

It adds scrutiny. Testosterone is Schedule III, telemedicine prescribing relies on DEA flexibilities that run through December 31, 2026, and LegitScript notes platforms watch for performance-enhancer framing. Keep ads on labs, clinicians and ongoing care.

**What should a TRT landing page say before certification?**

Lead with the program: the lab panel, the provider visit, follow-up care and the program price. State that a prescription is required and that a licensed provider decides. Keep drug names, doses and add-to-cart buttons off ad landing pages until authorization is live.

## Sources

- [Meta Advertising Standards: Drugs and Pharmaceuticals](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/) (checked October 5, 2026)
- [Meta Advertising Standards: Privacy Violations and Personal Attributes](https://transparency.meta.com/policies/ad-standards/objectionable-content/privacy-violations-personal-attributes/) (checked October 5, 2026)
- [Meta Advertising Standards: Health and Wellness (updated Jul 22, 2026)](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/health-wellness/) (checked October 5, 2026)
- [Meta Business Help Center: About prohibited information](https://www.facebook.com/business/help/361948878201809) (checked October 5, 2026)
- [21 CFR 1308.13, Schedule III controlled substances (eCFR)](https://www.ecfr.gov/current/title-21/chapter-II/part-1308/section-1308.13) (checked October 5, 2026)
- [Federal Register 2025-24123: Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications](https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled) (checked October 5, 2026)
- [LegitScript: Certified but still getting disapproved? Telehealth advertising webinar takeaways](https://www.legitscript.com/healthcare/certified-but-still-getting-disapproved-key-takeaways-from-our-telehealth-advertising-webinar/) (checked October 5, 2026)

## Related

- [How Do You Advertise TRT on Meta and Google Without Losing the Account?](https://medscale.health/answers/how-to-advertise-trt-on-meta-and-google)
- [How Do You Advertise a Telehealth Brand on Meta Without Losing the Ad Account?](https://medscale.health/answers/how-to-advertise-telehealth-on-meta)
- [Who Needs LegitScript Certification to Advertise Telemedicine?](https://medscale.health/answers/legitscript-certification-for-telemedicine)
- [What Should You Do When Meta Restricts Your Telehealth Ad Account?](https://medscale.health/answers/meta-ad-account-restricted-telehealth)

Canonical page: https://medscale.health/answers/can-you-advertise-trt-on-meta